ACRO BIOMEDICAL CO., LTD.
ACBM
|
$0.105
4471.43%
300
|
Wholesale Trade
(0.0% 1d) (0.0% 1m) (-96.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-85.0% volume)
Earnings Calendar:
Market Cap: $ 6,304,410
Sec Filling | Patents | 1 employees
acro biomedical co. is developing the next generation biomaterials to be used for tissue repairs in areas such as orthopedics, dentistry, cardiovascular grafts, ophthalmology, surgeries, wound repairs, sports injuries, and etc. we strive to use the cleanest technologies to produce the most natural biological scaffolds to improve patient quality of life.
add to watch list Paper trade email alert is off
Press-releases
What BioSpace Heard at the BIO CEO & Investor Conference
Published: 2022-02-17 (Crawled : 14:00) - biospace.com/
ACBM | $0.105 4471.43% 300
|
Wholesale Trade
| Email alert
Add to watchlist
space ceo conference spac
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10